The Acute-on-Chronic Liver Failure Syndrome, or When the Innate Immune System Goes Astray

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Immunology

• Publication date

  2016-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1600818PMID 27815438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 我が国におけるAcute-On-Chronic Liver Failure（ACLF）の診断基準（案）

  2018cited by this paper
• Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores

  2016cited by this paper
• Acute-on-chronic liver failure in cirrhosis

  2016cited by this paper
• Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation.

  2016cited by this paper
• Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).

  2016cited by this paper
• Lower number and decreased function of natural killer cells in hepatitis B virus related acute-on-chronic liver failure.

  2016cited by this paper
• Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure

  2016influential reference
• Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis

  2015cited by this paper
• Control of adaptive immunity by the innate immune system

  2015cited by this paper
• Dysbiosis‐induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice

  2015cited by this paper
• Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis.

  2015cited by this paper
• Sepsis-associated acute kidney injury.

  2015cited by this paper
• Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.

  2015cited by this paper
• Fight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis

  2015cited by this paper
• Mitochondrial function and disturbances in the septic kidney.

  2015cited by this paper
• RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.

  2014cited by this paper
• Stress, inflammation, and defense of homeostasis.

  2014cited by this paper
• University of Birmingham Patients With Acute-on-Chronic Liver Failure Have Increased Numbers of Regulatory Immune Cells Expressing the Receptor Tyrosine Kinase MERTK

  2014cited by this paper
• Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance.

  2014cited by this paper
• Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2

  2014cited by this paper
• Pathological bacterial translocation in liver cirrhosis.

  2014cited by this paper
• G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent.

  2014cited by this paper
• Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.

  2014cited by this paper
• Pediatric Lung Transplantation

  2014cited by this paper
• Mechanisms and functions of inflammasomes.

  2014influential reference
• High‐mobility group box‐1 in sterile inflammation

  2014influential reference
• Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

  2013influential reference
• Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis.

  2013cited by this paper
• Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms

  2013cited by this paper
• Eosinophils Preserve Parasitic Nematode Larvae by Regulating Local Immunity

  2012cited by this paper
• Natural killer cell recognition and killing of activated hepatic stellate cells

  2012cited by this paper
• Disease Tolerance as a Defense Strategy

  2012influential reference
• Macrophage plasticity and polarization: in vivo veritas.

  2012cited by this paper
• Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response

  2011cited by this paper
• IL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation

  2011cited by this paper
• Pattern recognition receptors and inflammation.

  2010influential reference
• Nomenclature of monocytes and dendritic cells in blood.

  2010cited by this paper
• Severe sepsis in cirrhosis

  2009cited by this paper
• Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.

  2009cited by this paper
• Interleukin-1beta and the autoinflammatory diseases.

  2009cited by this paper
• Alcoholic hepatitis.

  2009cited by this paper
• How dying cells alert the immune system to danger

  2008cited by this paper
• IL‐1, IL‐18, and IL‐33 families of cytokines

  2008cited by this paper
• Harmful molecular mechanisms in sepsis

  2008influential reference
• Hepatopulmonary syndrome--a liver-induced lung vascular disorder.

  2008cited by this paper
• A calculated response: control of inflammation by the innate immune system.

  2008cited by this paper
• DAMPs, PAMPs and alarmins: all we need to know about danger

  2007influential reference
• cDNA microarray analysis reveals fundamental differences in the expression profiles of primary human monocytes, monocyte‐derived macrophages, and alveolar macrophages

  2007cited by this paper
• The advent of the cytokine storm

  2007cited by this paper
• In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats.

  2007cited by this paper
• Mechanisms of sepsis-induced organ dysfunction

  2007cited by this paper
• Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M.

  2006influential reference
• Microbes, immunoregulation, and the gut

  2005cited by this paper
• Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.

  2005cited by this paper
• Increased apoptosis dependent on caspase-3 activity in polymorphonuclear leukocytes from patients with cirrhosis and ascites.

  2004cited by this paper
• Coagulation disorders in patients with cirrhosis and severe sepsis

  2003cited by this paper
• The role of the liver in the response to LPS: experimental and clinical findings.

  2002cited by this paper
• The immunopathogenesis of sepsis

  2002cited by this paper
• Review: The role of the liver in the response to LPS: experimental and clinical findings

  2002cited by this paper
• Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy.

  2002cited by this paper
• Annotating genes with potential roles in the immune system: six new members of the IL-1 family.

  2001cited by this paper
• Chemokines in pathology and medicine

  2001cited by this paper
• Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis.

  2000cited by this paper
• HMG-1 as a late mediator of endotoxin lethality in mice.

  1999cited by this paper
• Acute-phase proteins and other systemic responses to inflammation.

  1999influential reference
• Biologic basis for interleukin-1 in disease.

  1996cited by this paper
• Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival.

  1996cited by this paper
• Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial

  1994cited by this paper
• Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

  1994cited by this paper
• Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality.

  1993cited by this paper
• Interleukin-1 Beta

  1993cited by this paper
• Excessive in vitro bacterial lipopolysaccharide‐induced production of monokines in cirrhosis

  1990cited by this paper
• [Alcoholic hepatitis].

  1987cited by this paper

• From Liver to Brain: A 2.5D Deep Learning Model for Predicting Hepatic Encephalopathy Using Opportunistic Non-contrast CT in Hepatitis B Related Acute-on-Chronic Liver Failure Patients.

  2026cites this paper
• Comment on "Pancreatic involvement and its prognostic impact in acute-on-chronic liver failure".

  2026cites this paper
• Outcomes of Liver Transplantation Among Patients Diagnosed With Acute-on-Chronic Liver Failure: A Single-Center Experience.

  2025cites this paper
• Acute Liver Failure Complicated by Cytokine Storm: Diagnostic Dilemma and Management Strategies: A Case Report.

  2025cites this paper
• Perfil de internações não eletivas em pacientes cirróticos

  2025cites this paper
• Preascitic Sodium Retention in Cirrhosis: A Role for Disregulated Proteolysis by Proprotein Convertases?

  2025cites this paper
• FTY720 alleviates D-GalN/LPS-induced acute liver failure by regulating the JNK/MAPK pathway.

  2025cites this paper
• Single-cell RNA sequencing of peripheral blood mononuclear cells in patients with acutely decompensated cirrhosis reveals a specific monocyte subset associated with an increased risk of progression to ACLF

  2025cites this paper
• Interaction between post-tumor inflammation and vascular smooth muscle cell dysfunction in sepsis-induced cardiomyopathy

  2025cites this paper
• Higher prevalence of Cytomegalovirus and Epstein–Barr virus in acute-on-chronic liver failure

  2025cites this paper
• The Impact of Liver Failure on the Immune System

  2024cites this paper
• The impact of sex and body mass index in liver transplantation for acute‐on‐chronic liver failure

  2024cites this paper
• Metabolic Dysregulation and Metabolite Imbalances in Acute-on-chronic Liver Failure: Impact on Immune Status

  2024cites this paper
• Association between dust exposure and lung function levels in steelworkers: mediation analysis of inflammatory biomarkers

  2024cites this paper
• Acute and non‐acute decompensation of liver cirrhosis (47/130)

  2024cites this paper
• Artificial Liver Support with CytoSorb and MARS in Liver Failure: A Retrospective Propensity Matched Analysis

  2023cites this paper
• The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status

  2023cites this paper
• Challenges in Diagnosis and Therapeutic Approach of Acute on Chronic Liver Failure—A Review of Current Evidence

  2023cites this paper
• Growing Evidence for Survival Benefit with Plasma Exchange to Treat Liver Failure.

  2023cites this paper
• The value of NLR versus MLR in the short-term prognostic assessment of HBV-related acute-on-chronic liver failure.

  2023cites this paper
• SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease

  2023cites this paper
• Acute-on-Chronic liver failure – A brief overview

  2023cites this paper
• Innate immune cell dysfunction and systemic inflammation in children with chronic liver diseases undergoing transplantation.

  2023cites this paper
• Clinical Implication of Plasma CD163 in Patients With Acute-on-Chronic Liver Failure.

  2022cites this paper
• Current and future perspectives on acute-on-chronic liver failure: Challenges of transplantation, machine perfusion, and beyond

  2022cites this paper
• Liver support systems for adults with acute-on-chronic liver failure

  2022cites this paper
• Lower level of IL‐28A as a predictive index of the artificial liver support system in effective treatment of patients with HBV‐ACLF

  2022cites this paper
• Upregulation of microRNA-125b-5p alleviates acute liver failure by regulating the Keap1/Nrf2/HO-1 pathway

  2022cites this paper
• Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure

  2022cites this paper
• Recognizing Dysfunctional Innate and Adaptive Immune Responses Contributing to Liver Damage in Patients With Cirrhosis

  2021cites this paper
• Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections

  2021cites this paper
• Uncertainty in the impact of liver support systems in acute-on-chronic liver failure: a systematic review and network meta-analysis

  2021cites this paper
• Cyclophilin D‐dependent mitochondrial permeability transition amplifies inflammatory reprogramming in endotoxemia

  2021cites this paper
• Heart rate variability in patients with cirrhosis: a systematic review and meta-analysis

  2021cites this paper
• Hepatorenal syndrome: pathophysiology and evidence-based management update

  2021cites this paper
• Pathogenese und Progression der Leberzirrhose: aktuelle Perspektiven

  2021cites this paper
• A nomogram to predict survival in patients with acute-on-chronic hepatitis B liver failure after liver transplantation

  2021cites this paper
• Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives

  2021cites this paper
• Latent Cytomegalovirus Reactivation in Patients With Liver Failure: A 10-Year Retrospective Case-Control Study, 2011-2020

  2021cites this paper
• Development and Validation of a Clinical Predictive Model for Bacterial Infection in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

  2021cites this paper
• Hepatorenal Syndrome

  2021cites this paper
• Biglycan in hepatorenal crosstalk Biglycan: a regulator of hepatorenal inflammation and autophagy.

  2021cites this paper
• The Lipopolysaccharide-Sensing Caspase(s)-4/11 Are Activated in Cirrhosis and Are Causally Associated With Progression to Multi-Organ Injury

  2021cites this paper
• Gene Pro ling of Toll-like Receptor Signaling Pathways in Neutrophils of Patients With Acute-on- chronic Liver Failure

  2021cites this paper
• Establishment of a murine model of acute-on-chronic liver failure with multi-organ dysfunction

  2021cites this paper
• Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care—Report of two cases reports and review of the literature

  2021cites this paper
• Leveraging omics to understand the molecular basis of acute-on-chronic liver failure

  2021cites this paper
• The synergy of dietary supplements Lactobacillus salivarius LI01 and Bifidobacterium longum TC01 in alleviating liver failure in rats treated with D-galactosamine.

  2021cites this paper
• Impact of hepatocyte-specific deletion of staphylococcal nuclease and tudor domain containing 1 (SND1) on liver insulin resistance and acute liver failure of mice

  2021cites this paper
• Acute-on-Chronic Liver Failure

  2021cites this paper
• Early transplantation maximizes survival in severe acute-on-chronic liver failure: Results of a Markov decision process model

  2021cites this paper
• Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients

  2021cites this paper
• Chronic Xiao-chai-hu Decoction Therapy Slows the Progression of Acute-on-chronic Liver Failure via Prokinetic Effects on Gastrointestinal Motility

  2021cites this paper
• Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and Management

  2021cites this paper
• La aplicación de las ómicas para comprender la base molecular de la insuficiencia hepática aguda sobre crónica

  2021cites this paper
• Tenebrio molitor as a source of interesting natural compounds, their recovery processes, biological effects, and safety aspects.

  2021cites this paper
• Gene profiling of Toll-like receptor signalling pathways in neutrophils of patients with acute-on-chronic liver failure

  2021cites this paper
• The role of RIPK1 mediated cell death in acute on chronic liver failure

  2021cites this paper
• Mesenchymal stem cells regulated liver DX5- natural killer cells in acute-on-chronic liver failure

  2020cites this paper
• Soluble urokinase plasminogen activator receptor is associated with short-term mortality and enhanced reactive oxygen species production in acute-on-chronic liver failure

  2020influential citation
• Effect of the Hepatocyte-Speci c Deletion of SND1 in Mice on the Liver Insulin Resistance and Acute Liver Failure

  2020cites this paper
• Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis.

  2020cites this paper
• LC3-associated phagocytosis protects against inflammation and liver fibrosis via immunoreceptor inhibitory signaling

  2020influential citation
• Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute‐on‐chronic liver failure and acute decompensation

  2020cites this paper
• A Double-Blind, Randomized Placebo-Controlled Trial of Probiotic Lactobacillus casei Shirota in Stable Cirrhotic Patients

  2020cites this paper
• Patients with severe acute‐on‐chronic liver failure are disadvantaged by model for end‐stage liver disease‐based organ allocation policy

  2020cites this paper
• Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis

  2020cites this paper
• The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial

  2020cites this paper
• Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure

  2020cites this paper
• Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis

  2020cites this paper
• Solid Organ Injury

  2020cites this paper
• Influenza virus infection as precipitating event of acute-on-chronic liver failure.

  2019cites this paper
• Obesity and the Critically Ill Cirrhotic Patient

  2019cites this paper
• Pyroptosis in Liver Disease: New Insights into Disease Mechanisms

  2019cites this paper
• Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter?

  2019cites this paper
• Esdeveniments adversos posteriors a la colangiopancreatografia retrograda endoscòpica en els pacients amb cirrosi hepàtica i en els receptors de transplantament hepàtic

  2019cites this paper
• The immunological roles in acute-on-chronic liver failure: An update.

  2019cites this paper
• Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming of impaired regeneration pathways in mice.

  2019cites this paper
• Chinese Medicine Jiedu Huayu Granules Reduce Liver Injury in Rats by Regulating T-Cell Immunity

  2019cites this paper
• Increased Serum Soluble Urokinase Plasminogen Activator Receptor Predicts Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure

  2019cites this paper
• Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis?

  2019cites this paper
• Patients With Acute on Chronic Liver Failure Grade 3 Have Greater 14‐Day Waitlist Mortality Than Status‐1a Patients

  2019cites this paper
• Altered PGE2-EP2 is associated with an excessive immune response in HBV-related acute-on-chronic liver failure

  2019influential citation
• Characterization of the circulating microbiome in acute‐on‐chronic liver failure associated with hepatitis B

  2019cites this paper
• Systemic inflammation in hepatorenal syndrome – A target for novel treatment strategies?

  2019cites this paper
• Regulation of Monocyte-Macrophage Responses in Cirrhosis—Role of Innate Immune Programming and Checkpoint Receptors

  2019cites this paper
• Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis

  2019cites this paper
• Obesity and acute-on-chronic liver failure.

  2019cites this paper
• Infectious Complications in Critically Ill Liver Failure Patients

  2018cites this paper
• Acute-on-Chronic Liver Failure: From Basic Research to Clinical Applications

  2018cites this paper
• Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity

  2018cites this paper
• Update on acute-on-chronic liver failure.

  2018cites this paper
• The Role of Monocytes and Macrophages in Acute and Acute-on-Chronic Liver Failure

  2018cites this paper
• Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure

  2018cites this paper
• MiR‐19a Affects Hepatocyte Autophagy via Regulating lncRNA NBR2 and AMPK/PPARα in D‐GalN/Lipopolysaccharide‐Stimulated Hepatocytes

  2018cites this paper
• Acute on Chronic Liver Failure and Immune Dysfunction: A Mimic of Sepsis

  2018cites this paper
• Prognostic utility of novel biomarkers in acute‐on‐chronic liver failure (ACLF) associated with hepatitis B: A multicenter prospective study

  2018cites this paper
• Acute‐on‐chronic liver failure exists in patients with hepatitis B virus‐related decompensated cirrhosis

  2018cites this paper
• Update on acute-on-chronic liver failure.

  2018cites this paper
• Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.

  2018cites this paper